Keros Therapeutics (KROS) Change in Taxes (2025)

Keros Therapeutics (KROS) reported Change in Taxes of -$1.9 million for Q4 2025, up 12.74% quarter-over-quarter from -$2.2 million in Q3 2025.

Keros Therapeutics (KROS) Change in Taxes (2025) Analysis & Trends

Keros Therapeutics has reported Change in Taxes for 1 years, with the latest figure at -$1.9 million in Q4 2025.

For the quarter ending Q4 2025, Change in Taxes changed N/A year-over-year to -$1.9 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (changed N/A YoY), and the FY2025 full-year result was $2.2 million, changed N/A from the prior year.
Change in Taxes for Q4 2025 stood at -$1.9 million, up from -$2.2 million in the prior quarter.
The five-year high for Change in Taxes was $10.0 million in Q1 2025, with the low at -$3.7 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Keros Therapeutics	399.01 Mn	111.61 Mn	-	-1.90 Mn

Download Data